期刊文献+

微阵列酶联免疫技术在ToRCH-IgG抗体检测中的应用 被引量:1

下载PDF
导出
摘要 目的将微阵列酶联免疫技术(AE)应用于ToRCH-IgG抗体检测,评价其临床应用价值。方法用AE法对400例孕妇血清标本进行ToRCH-IgG抗体检测,同时用德国维润塞润公司ToRCH系列检测试剂盒(ELISA法)进行结果比对,对两法阳性率和一致性进行分析。结果 AE法与ELISA法检测ToRCH各病原体IgG抗体的阳性率均无显著性差异(P>0.05),两法结果符合率达98.5%,一致性检验kappa值为0.945,结果高度一致。结论 AE法可同时快速自动化获得ToRCH 5种病原体IgG抗体的结果,具有较好的临床应用价值。
出处 《临床检验杂志》 CAS CSCD 北大核心 2012年第8期633-634,共2页 Chinese Journal of Clinical Laboratory Science
  • 相关文献

参考文献3

二级参考文献22

  • 1张肖民,张荣娜,林淑钦,陈水仙,郑丽英.妊娠梅毒192例临床分析[J].中华妇产科杂志,2004,39(10):682-686. 被引量:79
  • 2朱丽青,赵秘胜,叶松道.温州地区产妇HBV、梅毒、HCV及HIV感染情况调查分析[J].中国计划生育学杂志,2006,14(2):105-107. 被引量:6
  • 3Newton ER. Diagnosis of perinatal TORCH infections. Clin Obstet Gynecol, 1999,42:59-70.
  • 4Hill JB, Sheffield JS, Kim MJ,et al. Risk of hepatitis B transmission in breast-fed infant of chronic hepatitis B carriers. Obstet Gynecol, 2002, 99 : 1049-1052.
  • 5中华医学会肝病分会,中华医学会感染病学分会.慢性乙型肝炎防治指南.中华医学论坛报,2006-01-27.
  • 6庄辉.免疫球蛋白在预防乙肝中需要澄清的问题.中华医学论坛报,2006-06-01.
  • 7Alexander JM, Sheffield JS, Sanchez PJ,et al. Efficacy of treatment for syphilis in pregnancy. Obstet Gynecol,1999,93:5-8.
  • 8Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Special considerations. Pregnancy. In HIV infections : detection, counseling, and referral. MMWR, 2006,55 ( RR-11 ) : 10-20.
  • 9Public task force recommendations for the used of antiretroviral drugs in pregnancy HIV-1 infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Rockville, MD: U S. Department of Health and Human Services Administration,2005.
  • 10American College of Obstetricians and Gynecologists. Scheduled cesarean delivery and the prevention of vertical transmission of HIV infection. ACOG Committee Opinion 234. Washington DC :American College of Obstetricians and Gynecologists, 2000:

共引文献31

同被引文献8

  • 1侯林浦,姜英涛,高英,张萌,马旭.巨细胞病毒IgG抗体亲和指数测定的方法及临床意义[J].中华临床医学荟萃杂志,2004,1(1):14-17. 被引量:5
  • 2Mezzasoma L, Bacarese H amihon T, Di Cristina M, ct ak Antigen microarrays for serodiagnosis of infectious diseases [J ]. Clin Chem, 2002,48( 1 ) : 121-130.
  • 3Petersen E, Borobio MV, Guy E, et al. European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii specific immunoglobulin G (IgG) and lgM and thelgG avidity index[J]. J Clin Microbiol, 2005 ,47;(4)=1570 157/1.
  • 4Perciani CT,Peixoto PS,Dias WO,et al. Improved method to cal- culate the antibody avidily index[J]. J Clin Lab Anal, 2007,21 (3) :201-206.
  • 5Hamkar R ,Jalivand S, Mokhtari Azad T, et al. Assessment of IgM enzyme immunoassay and lg(; avidity assay for distinguishing be- tween primary and secondary immune response to rubella vaccine [J]. Virol Methods, 2005,130(1/2) : 59-65.
  • 6Bod6us M, Feyder S, Goubau P. Avidity of IgG antibodies distin guishes primary from non primary cytomegalovirus infection in pregnant women[J]. Clin Diagn Virol, 1998,9 ( 1 ) : 9 16.
  • 7董悦,廖秦平.如何重新评价与解释围产期TORCH感染筛查[J].中华检验医学杂志,2008,31(7):742-746. 被引量:29
  • 8盛秋,李芬.妊娠期人巨细胞病毒原发性感染的诊断与预防[J].国外医学(妇幼保健分册),2004,15(2):99-102. 被引量:3

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部